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The de novo immune response to infectious organisms arises from the innate recognition of pathogen-
associated molecular patterns (PAMPs) by the host’s pattern recognition receptors (PRRs). As the generation
of type 2 cytokine responses by the human trematode parasite Schistosoma mansoni is glycan mediated, there
is a particular potential role for a C-type lectin receptor (CLR) to mediate the innate recognition of schisto-
some PAMPs. One such CLR, dendritic cell-specific intracellular adhesion molecule-3-grabbing nonintegrin
(DC-SIGN; CD209), has been shown to recognize glycans expressed by S. mansoni eggs. We show that SIGNR1
(SIGN-related 1; CD209b), a murine homologue of DC-SIGN that is expressed on macrophages, also binds
both schistosome-soluble egg antigens and worm antigens in vitro. The generation of schistosome egg-induced
pulmonary egg granulomas was not altered in SIGNR1-deficient mice. Following S. mansoni infection, the
SIGNR1-deficient mice had an unaltered phenotype with an intact immunological response and no difference
in pathology. In this study we demonstrate that although SIGNR1 recognizes S. mansoni antigens in vitro, this
CLR is redundant during infection. This study highlights the finding that although there was binding of
SIGNR1 to immunogenic factors produced in the S. mansoni life cycle, this recognition does not translate to a
functional in vivo role for the PRR during infection.
Schistosoma is a genus of parasitic digenetic trematodes that
chronically infect more than 200 million people in developing
countries, causing the tropical disease schistosomiasis. A major
aspect of pathology during Schistosoma mansoni infection is
immune mediated, with the infected hosts evoking inflamma-
tory responses against the parasite eggs, which become trapped
in host organs (25, 39). In S. mansoni-infected individuals there
is a preferential deposition of parasite eggs in the liver and
intestines. Consequently, these organs develop the granuloma-
tous inflammation and fibrosis that are clinical features of S.
mansoni infections. The characteristic immune response fol-
lowing S. mansoni infection is a polarized type 2 cytokine
response, with elevated interleukin-4 (IL-4), IL-5, and IL-13
production and consequent eosinophilia, fibrosis, and produc-
tion of immunoglobulin E (IgE). The genesis of the type 2
response following infection is primarily attributed to the po-
tent type 2 cytokine-stimulating capacity of S. mansoni eggs
and soluble egg antigens (SEAs) (36). SEA is highly glycosy-
lated, and the antigen’s capacity to induce type 2 responses is
glycan dependent, with SEA deglycoslated by periodate treat-
ment having diminished type 2 responses when administered to
mice (22, 31). As these schistosome egg glycoconjugates evoke
a marked skewing of the immune response toward a type
2-biased phenotype, there is considerable interest in the mech-
anisms of antigen-presenting cell (APC) recognition of glycans
in SEAs. Schistosome glycoconjugates function as pathogen-
associated molecular patterns (PAMPs) that modulate the in-
nate immune response via interaction with pattern recognition
receptors expressed on antigen-presenting cells.
While the Toll-like receptors represent the most extensively
characterized family of pattern recognition receptors, there is
an increasing understanding of the role of C-type lectin recep-
tors (CLRs) in innate immune activation by schistosome gly-
cans. One CLR expressed on human dendritic cells (DCs) is
DC-specific intracellular adhesion molecule-3-grabbing nonin-
tegrin (DC-SIGN; CD209), which is implicated in the recog-
nition of glycans from various pathogens including schisto-
somes (6, 33). DC-SIGN has been shown to bind glycans in
S. mansoni SEAs, including the LewisX trisaccharide con-
taining carbohydrate lacto-N-fucopentaose III (LNFPIII)
and GalNAcb1-4(fuca1-3)GlcNAc (1, 32, 34). In addition, a DC-
SIGN homologue, L-SIGN, that is expressed on liver sinusoi-
dal endothelial cells also binds SEA (34) but recognizes dif-
ferent SEA glycans than DC-SIGN (20). In terms of the innate
induction of type 2 responses by schistosomes, modulation of
DCs to a DC2 phenotype following SEA treatment has been
well described (10, 18), with the egg glycan LNFPIII driving
the generation of DC2s (30).
In view of the known role for glycans in immune modulation
by schistosomes, we investigated the interactions of the mouse
CLR SIGNR1 (SIGN-related 1; CD209b). SIGNR1 is one of 7
paralogues of DC-SIGN described in mice in a family which
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also contains a related pseudogene, SIGNR6 (24, 26). Whether
SIGNR1 is expressed on DC subsets is not as yet clear, but it
is expressed on spleen marginal zone (MZ), lymph node, and
peritoneal macrophages (7, 12, 23, 24, 29). SIGNR1 is known
to recognize glycans from different pathogens and has been
shown to bind LewisX/Y- and LewisA/B-containing carbohy-
drates (6, 13). In this study we demonstrate that while SEAs
and also schistosome worm antigens are bound by SIGNR1 in
vitro, the use of SIGNR1-deficient (/) mice (16) reveals
that in the absence of the receptor, no alterations in the im-
munological and pathological response occur following S.
mansoni egg injection or during acute and chronic infection.
MATERIALS AND METHODS
Mice and parasite infection. SIGNR1/ mice (16) were backcrossed for eight
generations to the BALB/c strain. Mice were housed under specific-pathogen-
free conditions. Animals were fed irradiated diet and housed on irradiated
bedding in individually ventilated and filtered cages under positive pressure
(Tecniplast, Northants, United Kingdom). A Puerto Rican strain of S. mansoni
was maintained by passage in BALB/c mice and albino Biomphalaria glabrata
snails. Six- to eight-week-old SIGNR1/ and wild-type BALB/c mice were
infected percutaneously with 25 cercariae. Mice were culled at 8 and 16 weeks
postinfection. All animal experiments were performed in compliance with Irish
Department of Health and Children regulations and approved by the Trinity
College Bioresources ethical review board.
Parasitology and pathology. S. mansoni adult worm antigen (AWA) and SEAs
were prepared as described previously (5). AWAs and SEAs were screened for
endotoxin contamination, and only antigen batches containing 1 endotoxin
unit/mg (Chromogenic LAL, Biowhittaker, MD) were used. Portal perfusion for
worm recovery and liver, intestinal, and fecal egg counts were as described
previously (4). Parasite fecundity was determined by dividing total tissue (liver
and intestine) egg counts by the number of worm pairs present. Livers from mice
were taken and fixed in 10% formaldehyde-saline for histology. Sections of liver
were stained with hematoxylin and eosin for egg granuloma diameter measure-
ments and Giemsa-stained for eosinophil quantification. Hepatic fibrosis was
measured by quantification of collagen by differential staining of histology sec-
tions (4). Fibrosis is expressed as micrograms of collagen per milligram of
protein. To quantify the extent of liver damage in mice, plasma was recovered for
analysis of aspartate aminotransaminase (AST) levels (4).
Cell culture and immunological analysis. Spleens or mesenteric lymph nodes
were removed and passed through 70-m-pore-size sieves (Falcon) to prepare
single-cell suspensions. Cells from liver granulomas were isolated as described
previously (37). Splenocytes were depleted of erythrocytes by lysis with ammo-
nium chloride solution. Cells were cultured in RPMI 1640 medium (Biowest,
United Kingdom) supplemented with 10% (vol/vol) heat-inactivated fetal calf
serum (Labtech, United Kingdom), 2 mM L-glutamine (Gibco), 50 U/ml peni-
cillin, and 50 g/ml streptomycin (Gibco). Cell suspensions were unstimulated
(medium) or stimulated with 2.5 ng/ml phorbal 12-myristate 13-acetate (PMA;
Sigma, United Kingdom) and 250 ng/ml ionomycin (Sigma, United Kingdom),
SEA (20 g/ml), or AWA (20 g/ml) at 37°C. Supernatants were harvested after
72 h and stored frozen. Sandwich enzyme-linked immunosorbent assays
(ELISAs) were performed to quantify levels of specific cytokines in the super-
natants from cell cultures. Reagents for detection of IL-4 were from BD Phar-
mingen (United Kingdom), and gamma interferon (IFN-), IL-10, and tumor
necrosis factor alpha (TNF-) reagents were purchased from R&D Systems
(United Kingdom). Serum antigen-specific antibody (IgG and IgE) responses to
SEA were measured using ELISAs, as described previously (4).
SIGNR1 binding assay. NIH 3T3 fibroblasts stably expressing SIGNR1 were
generated as described previously (29) and cultured in Dulbecco’s modified
Eagle’s medium (Invitrogen, Paisley, United Kingdom) supplemented with 10%
heat-inactivated fetal calf serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 2
mM L-glutamine, and 0.6 mg/ml G418 (Invitrogen). Ligands for SIGNR1 were
assessed by competitive binding assays as previously described (29). In brief, NIH
3T3 cells expressing SIGNR1 were plated in 24-well plates the day before
experiments. Cells were washed three times with ice-cold medium prior to
addition of mannan as an inhibitor for 1 h at 4°C. After pretreatment, fluorescein
isothiocyanate (FITC)-labeled zymosan (at a zymosan-to-cell ratio of 20:1) was
added for 1 h at 4°C. After incubation, unbound zymosan was removed by four
washes with medium, and cells were lysed with 3% Triton X-100. FITC in lysates
was quantified using a Titer-Tek Fluoroskan II instrument (Labsystems Group,
Basingstoke, United Kingdom) and expressed as relative fluorescence units.
Statistical analysis. All in vivo experiments were performed at least two
separate times. The difference between groups was analyzed by a Student’s t test.
P values of 0.05 were considered significant.
RESULTS
SIGNR1 binds schistosome worm and egg antigens. As S.
mansoni SEA glycans are known to bind to DC-SIGN (1, 32),
we investigated whether soluble antigens from S. mansoni eggs
and worms were recognized by SIGNR1. Schistosome SEAs or
AWAs were tested in a FITC-zymosan binding assay using
NIH 3T3 cells transfected with SIGNR1 (29). In this assay the
binding of FITC-zymosan to SIGNR1-transfected cells was
blocked by addition of mannan as an inhibitor, which is bound
by SIGNR1 (21) but not by rat IgG (Fig. 1). Both SEA and
AWA bound to SIGNR1 in a dose-dependent manner (Fig. 1).
Therefore, using an in vitro cell-binding assay, we show that
glycans within S. mansoni egg and worm antigens are recog-
nized and bound by SIGNR1.
SIGNR1-deficient mice have normal egg-induced pulmo-
nary granulomas. SIGNR1 has been shown to bind glycans
from a range of pathogens in vitro, including Streptococcus
pneumoniae (11). Following S. pneumoniae infection of
SIGNR1/ mice, a protective role for the in vivo interactions
between S. pneumoniae and SIGNR1 has been shown, with
altered pathogenesis and pulmonary response in SIGNR1/
mice (15, 16). As egg antigens were bound by SIGNR1 in vitro
(Fig. 1), we used the schistosome egg-induced pulmonary gran-
uloma model to investigate whether SIGNR1/ mice had an
intact capacity to generate egg-specific pulmonary immune
responses. In this model schistosome eggs are injected intra-
venously to induce Th2-mediated eosinophil-rich granuloma in
the lungs, with the result that mice presensitized by intraperi-
toneal egg injection have greater secondary pulmonary re-
sponses (19). The innate response following intravenous injec-
tion of eggs into mice evoked granulomatous inflammation
around eggs trapped in the lungs, with no difference between
wild-type and SIGNR1/ mice in the sizes of the cell infiltra-
tion surrounding the eggs (Fig. 2A). Similarly, the sizes of
FIG. 1. Testing binding of S. mansoni antigens to SIGNR1 in vitro.
SIGNR1-transfected NIH 3T3 cells were preincubated with no inhib-
itor (), a known SIGNR1 binding sugar (mannan; 200 g/ml), S.
mansoni SEAs, or AWAs (3, 30, and 300 g/ml), or rat IgG. FITC-
conjugated zymosan was added, and bound FITC was quantified using
a fluorimeter (as described in Materials and Methods) and is expressed
as relative fluorescence units. Data are representative of two experi-
ments and are expressed as means  standard error of the means of
duplicate samples.
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pulmonary egg granulomas were comparable in both groups of
mice that had been presensitized to schistosome eggs (Fig. 2C),
with no differences in the cell composition of the granuloma
between wild-type and SIGNR1/ mice (data not shown).
The levels of Th1 (IFN-), Th2 (IL-4), and regulatory (IL-10)
cytokine proteins in the lungs of both groups were no different
following primary (Fig. 2B) and secondary (Fig. 2D) egg chal-
lenge. These data show that there is no defect in pulmonary
response in SIGNR1/ mice after challenge with Schistosoma
eggs.
SIGNR1-deficient mice have normal acute and chronic S.
mansoni infections. SIGNR1 is expressed primarily on perito-
neal and spleen MZ macrophages (12), with very little or no
SIGNR1 expression being found on DCs, alveolar macro-
phages, B cells, or T cells (7, 12, 23, 24, 29). Thus, the absence
of alterations in schistosome egg-induced pulmonary response
in SIGNR1/ mice (Fig. 2) could be due to the lack of
expression of SIGNR1 on lung alveolar macrophages. In view
of the essential role for macrophages in S. mansoni infection
(8), SIGNR1/ and wild-type mice were infected with S.
mansoni, and the immunological response and pathology were
compared between groups. Following infection, parasitological
and immune responses of SIGNR1/ and wild-type animals
were analyzed at the acute 8-week stage of infection and the
chronic down-modulated stage of infection at 16 weeks.
There were no statistical differences in the range of parasi-
tological and pathological responses between SIGNR1/ and
wild-type mice following schistosome infection. Worm fecun-
dity and fecal egg excretion were unaltered in deficient mice
(Fig. 3A and B), and the size and eosinophil content of gran-
ulomas surrounding eggs in the liver were comparable, as were
the levels of hepatic fibrosis (Fig. 3C to E). Consistent with
normal liver pathology in schistosome infection and intact egg
excretion, there were no differences in plasma levels of AST
(Fig. 3F), a marker for hepatocyte damage in S. mansoni in-
fection of mice (4). Furthermore, the deficient mice developed
the normal downmodulation in inflammatory responses seen in
chronic stages of infection, with smaller-sized granulomas in
both groups of mice in the chronic stages versus acute stages of
infection (Fig. 3C). A characteristic of the hepatic pathology in
S. mansoni-infected mice is the upregulation of Arg-1 in the
liver, consistent with an increase in alternatively activated mac-
rophages in the liver (9). S. mansoni-infected wild-type and
SIGNR1/ mice had marked elevations in Arg-1 mRNA lev-
els in the livers relative to uninfected mice, with no differences
in Arg-1 expression between groups (data not shown). Indeed,
IL-4-induced expression of alternatively activated genes Fizz-1,
Ym-1, and Arg-1 by peritoneal macrophages was comparable
between wild-type and SIGNR1/ mice (data not shown),
indicating no in vivo or in vitro defect in alternative activation
of SIGNR1/ macrophages.
Spleens and mesenteric lymph nodes were removed from
uninfected mice and animals with an acute or chronic infec-
tion. Granulomas were separated from livers, and granuloma
cells were isolated. Cells were simulated in vitro with PMA/
ionomycin, SEA, or AWA. The secretion of IL-4, IFN-, IL-
10, and TNF- were detected by ELISA as these cytokines are
FIG. 2. Evaluation of primary and secondary S. mansoni egg pul-
monary granulomas in wild-type (WT) and SIGNR1/ (KO) mice.
For study of the primary granulomas, mice were injected intravenously
with 5,000 eggs. After 14 days the lungs were removed and fixed for
histology sections for measurement of the volume of pulmonary egg
granulomas (A), or lungs were isolated and homogenized for ELISA
detection of Th1 (IFN-), Th2 (IL-4), and regulatory (IL-10) cytokine
protein, adjusted to nanograms of cytokine per milligram of protein
(B). To evoke secondary granulomas, mice were presensitized intra-
peritoneally with 5,000 eggs and injected 14 days later with 5,000 eggs
intravenously. Similar to primary granulomas, 14 days later lungs were
removed, and granuloma volume (C) or lung cytokine protein produc-
tion (D) was evaluated. Data are means standard error of the means
from 14 to 17 mice per group. A Student’s t test was used to test for
statistical differences between groups. NS, nonsignificant.
FIG. 3. Parasitology and pathology following S. mansoni infection
of wild-type (WT) and SIGNR1/ (KO) mice. Mice were infected
with 25 cercariae and culled in acute (8 weeks) and chronic (16 weeks)
stages of infection. Worm fecundity (eggs per worm pair) (A) and egg
excretion (eggs per gram of feces; [epg]) in the feces (B) were deter-
mined. The diameter (C) and eosinophil composition (percentage of
granuloma cells) (D) of granulomas surrounding eggs in the liver were
quantified. Hepatic fibrosis, expressed as micrograms of collagen per
milligram liver protein (E), and plasma levels of AST, a marker for
hepatocyte damage in S. mansoni infection of mice (F), were analyzed.
Data are means  standard error of the means from 13 to 17 mice per
group at 8 weeks and from 9 to 12 mice per group at 16 weeks. A
Student’s t test was used to test for statistical differences between
groups at acute and chronic stages of infection. NS, nonsignificant.
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implicated in altered immunopathology in schistosome infec-
tion of mice (39). Following polyclonal stimulation with PMA/
ionomycin, there were no differences in cytokine production
between wild-type and SIGNR1/ mice (Fig. 4). Further-
more, even though SIGNR1 bound SEA and AWA in vitro
(Fig. 1), spleen cells from schistosome-infected SIGNR1/
mice had intact cytokine responses to these antigens upon
restimulation (Fig. 4). We also observed no differences in cy-
tokine production by cells from the mesenteric lymph nodes or
granuloma (data not shown). In addition, there was no differ-
ence in the production of SEA-specific IgG and IgE antibodies
between wild-type and schistosome-infected SIGNR1/ mice
(data not shown).
DISCUSSION
Since schistosome SEA has been shown to bind human DC-
SIGN (1) and since the receptor is similar to the murine DC-
SIGN homologue SIGNR1, we explored whether S. mansoni
SEA and AWA were also recognized by SIGNR1. We show
using an in vitro cell transfection assay that glycans from both
SEAs and AWAs bind SIGNR1 in a dose-dependent manner,
thus illustrating recognition of glycoconjugates expressed on
two different stages of the parasite life cycle by murine
SIGNR1. This is the first report of the binding of schistosome
antigens by SIGNR1.
To investigate the role of SIGNR1 recognition of schisto-
some antigens in vivo, we used SIGNR1/ mice (16). We
demonstrated that SIGNR1 has no role in a primary or sec-
ondary pulmonary granuloma model induced by schistosome
eggs, with deficient mice exhibiting an intact capacity to gen-
erate an immune response toward egg antigens. Considering
that, to date, SIGNR1 expression has been attributed almost
exclusively to macrophage populations of the spleen MZ,
lymph nodes, and the peritoneum (7, 12, 29), an absence of its
expression on alveolar macrophages could have accounted for
the lack of an altered immune response in the pulmonary
granulomatous model. However, in pulmonary challenge mod-
els with S. pneumoniae, SIGNR1 recognizes S. pneumoniae
polysaccharides in in vitro assays, and the SIGNR1/ mice
used here have been shown to be more susceptible than wild-
type mice to infection (15, 16). In contrast, although SIGNR1
binds Mycobacterium tuberculosis mannosylated lipoarabino-
mannan (14), infection of SIGNR1/ mice indicated a limited
role for the molecule during infection (38). Indeed, discrepan-
cies between in vitro recognition of pathogen PAMPs by CLRs
and the functional role for the CLRs during in vivo infection
are features of a number of bacteria (27).
In order to fully elucidate any potential immunological role
for SIGNR1 during S. mansoni infection, we infected
SIGNR1/ mice. Analysis of a range of immunological, par-
asitological, and pathological infection-related parameters
demonstrated that SIGNR1/ mice are comparable to wild-
type animals. There was no difference between groups at the
acute (8 week) and chronic (16 week) stages of infection, with
SIGNR1/ mice developing the normal downmodulation of
granulomatous inflammation that occurred in wild-type mice
during chronic stages of infection. Furthermore, while
SIGNR1-transfected cells bound SEA and AWA in an in vitro
assay, restimulation of spleen, mesenteric, or granuloma cells
from schistosome-infected SIGNR1/ mice with SEA or
AWA showed intact production of IFN-, IL-4, IL-10, and
TNF-. These are cytokines implicated in altered immunopa-
thology in schistosome infection of mice (3, 39). Consistent
with no alterations in infection-induced immunity, the levels of
SEA-specific IgE and IgG and also anti-AWA (data not
shown) in schistosome-infected SIGNR1/ mice were no dif-
ferent from those of the wild-type group. Alternatively acti-
vated macrophages are induced in schistosome infection of
mice (9) in part via the egg glycan LNFPIII (2), with alterna-
tively activated macrophages having an essential biological role
in infection (8). Consistent with the absence of exacerbated
pathology, there were no differences between wild-type and
SIGNR1/ mice in the in vitro or in vivo expression of alter-
natively activated macrophage markers. Even in heavier, more
acute experimental infections (using 100 cercariae), there were
also no differences in mortality or inflammatory responses be-
tween wild-type and SIGNR1/ mice (data not shown). These
data indicate that in the absence of SIGNR1, mice develop a
normal S. mansoni infection.
In a recent in vitro study, multiple CLRs were shown to be
involved in the binding and internalization of SEA by DCs,
suggesting that DC-SIGN functions in tandem with other
CLRs for antigen processing and presentation to occur in re-
sponse to SEA (35). In our studies the absence of an in vivo
effect in SIGNR1/ mice may be due to the redundancy of
this molecule, with other macrophage CLRs, such as other
SIGNR molecules, the mannose receptor, or macrophage ga-
lactose-type lectin, compensating in recognition of schistosome
glycans. Consequently, a number of in vivo studies with mice
deficient in CLRs, such as the mannose receptor (17), would
Uninfected       
IL-4
 S.mansoni-infected
Acute               Chronic
IFN-γ
TNF-α
IL-10
WT                 KO
FIG. 4. Production of cytokines from spleen cells from uninfected
and S. mansoni-infected wild-type (WT) and SIGNR1/ (KO) mice.
Spleens were removed, and prepared cell suspensions were cultured in
vitro in medium alone, PMA/ionomycin, AWA, or SEA. After 72 h
supernatants were assayed by ELISA for IL-4, IFN-, IL-10, and
TNF-. Data shown are means  standard error of the means from 2
to 4 individual spleens and are representative of at least three exper-
iments per time point.
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undoubtedly prove informative as to which molecules schisto-
somes target in order to modulate the host toward a type 2
immune response. As shown here with SIGNR1, due to the
potential for redundancy and compensatory recognition of gly-
cans, mice with multiple CLR depletions may be required.
Ultimately, in the context of the biological function of CLRs in
human schistosome infection, studies on the role of DC-SIGN
are required. Such studies may be helped by a recent trans-
genic mouse model designed to express human DC-SIGN.
Transgenic mice have been generated that express human DC-
SIGN under the control of the CD11c promoter; these re-
vealed a new perspective on the role of DC-SIGN in M. tuber-
culosis infection (28).
In summary, this study demonstrates that although there was
binding of SIGNR1 to immunogenic factors produced in the S.
mansoni life cycle, this does not translate to the receptor hav-
ing in vivo function during S. mansoni infection or egg-induced
pulmonary responses. These data illustrate the need for cau-
tion when extrapolating from in vitro binding of PAMP in
transfected cell assays to biological function during infection.
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